Skip to main content

Table 4 Response to OnabotA

From: CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA

 

No (n)

Yes (n)

rs145837941 (CALCA)

 AA

18

63

 AG

0

0

 GG

0

0

rs1800497 (DRD2)

 AA

1

2

 AG

7

25

 GG

15

38

rs2201169 (GABRA3)

 TT

28

80

 TC

8

38

 CC

0

2

rs1139916 (GABRE)

 AA

6

10

 CA

14

57

 CC

16

53

rs6691840 (GRIK3)

 AA

23

66

 AC

13

43

 CC

0

9

rs734784 (KCNS1)

 GG

8

29

 GA

14

56

 AA

13

34

rs1050316 (MEF2D)

 TT

16

51

 TG

17

56

 GG

3

13

rs121434294 (MTHFR)

 CC

19

68

 CT

0

0

 TT

0

0

rs2230912 (P2RX7)

 AA

27

85

 AG

8

28

 GG

1

3

rs7640543 (TGFBR2)

 AA

4

11

 AG

17

60

 GG

15

49

rs222741 (TRPV1)

 TT

18

64

 TC

15

51

 CC

2

5

rs222749 (TRPV1)

 AA

3

1

 GA

3

8

 GG

30

111

rs734312 (WFS1)

 AA

12

34

 AG

14

55

 GG

9

31

rs3781719 (CALCA)

 TT

9

63

 TC

21

45

 CC

3

9

rs4354668 (EAAT2)

 GG

3

22

 GT

16

54

 TT

17

43

rs6627221 (GABRA3)

 CC

1

3

 CT

8

44

 TT

27

73

rs3810651 (GABRQ)

 TT

7

19

 TA

17

55

 AA

11

42

rs3813929_1732 (HTR2C)

 TT

1

2

 CT

15

35

 CC

20

82

rs11172113 (LRP1)

 CC

4

13

 CT

18

49

 TT

14

58

rs1835740 (MTDH)

 GG

24

73

 GA

10

43

 AA

2

4

rs1718119 (P2RX7)

 TT

3

17

 TC

16

47

 CC

17

55

rs6746030 (SCN9A)

 GG

29

88

 AG

6

30

 AA

1

1

rs10166942 (TRPM8)

 TT

25

85

 TC

9

32

 CC

2

3

rs222747 (TRPV1)

 GG

21

70

 GC

12

43

 CC

3

6

rs7217270 (TRPV3)

 AA

9

21

 AG

16

54

 GG

11

45